Key result
Handy EKG prototype achieves 96% diagnostic coincidence with conventional 12-lead ECG in healthy volunteers.
Why the study?
Cardiovascular diseases cause significant mortality worldwide and in Honduras, prompting the design of a low-cost three-lead electrocardiograph for primary care.
Does a low-cost three-lead electrocardiograph prototype provide equivalent lead I readings compared to a conventional 12-lead ECG in healthy volunteers?
Cross-Sectional (n=51)
No
Does a low-cost three-lead electrocardiograph prototype provide equivalent lead I readings compared to a conventional 12-lead ECG in healthy volunteers?
A low-cost, portable three-lead ECG prototype provides lead I readings and basic diagnostic capabilities comparable to a conventional 12-lead ECG, offering a potential screening tool for resource-limited primary care settings.
Answers are grounded in this paper and cite their sources.
May support low-cost ECG screening development in primary care; leaves open validation in symptomatic patients.
Background Cardiovascular diseases constitute the majority of noncommunicable disease deaths worldwide. In Honduras, cardiovascular diseases represent the fifth cause of death among individuals aged 45 to 49 years, while 20% of emergency room visits are due to cerebrovascular events, heart failure, and acute myocardial infarction. Methodology A low-cost three-lead electrocardiograph (ECG) (Handy EKG) was designed and manufactured for primary care. The device is supported by Bluetooth connectivity and machine learning. Device readings were collected from volunteers and compared to those obtained with a conventional 12-lead ECG. Results The device provided readings of lead one of a TDOU model CMS600G 12-lead ECG to monitor and diagnose bradyarrhythmia and tachyarrhythmias. Overall, 96% (49) of the readings showed a similarity in morphology, amplitude, and duration of waves, segments, and complexes compared to a 12-lead ECG. The device showed potential for application in primary care and intrahospital settings due to its continuous monitoring capabilities, portability, and possible connectivity with mobile devices. Conclusions The results indicate that the designed platform is safe, offers good quality in its operation at all levels, and provides ECG results equivalent to those of a conventional ECG in most cases (considering only one lead).
No takes yet. Share an insight, caveat, or question.
Solano et al. (2023) conducted a cross-sectional in Healthy volunteers (n=51). Handy EKG (low-cost three-lead electrocardiograph) vs. Conventional 12-lead ECG (TDOU model CMS600G) was evaluated on Diagnostic coincidence (similarity in morphology, amplitude, and duration of waves, segments, and complexes). The Handy EKG low-cost electrocardiograph prototype demonstrated a 96% diagnostic coincidence with a conventional 12-lead ECG in healthy volunteers.
Synapse has enriched 10 related papers. Consider them for comparative context: